Diagnosis, investigation and management of breast implant illness: a narrative review

**Introduction**: An increasing pool of literature proposes a link between silicone implants and autoimmune-related symptoms known colloquially as breast implant illness (BII). We describe the history of BII, the reported symptoms, risk factors and previously published diagnostic criteria with the a...

Full description

Bibliographic Details
Main Authors: Daniel WH Wong, Tai K Lam
Format: Article
Language:English
Published: Australian Society of Plastic Surgeons 2021-03-01
Series:Australasian Journal of Plastic Surgery
Online Access:https://doi.org/10.34239/ajops.v4n1.210
_version_ 1797341559858921472
author Daniel WH Wong
Tai K Lam
author_facet Daniel WH Wong
Tai K Lam
author_sort Daniel WH Wong
collection DOAJ
description **Introduction**: An increasing pool of literature proposes a link between silicone implants and autoimmune-related symptoms known colloquially as breast implant illness (BII). We describe the history of BII, the reported symptoms, risk factors and previously published diagnostic criteria with the aim to aid clinicians in the diagnosis, investigations and management of patients presenting with symptoms that they attribute to their silicone breast implants. **Methods**: A literature search was performed using MEDLINE®, the Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials (CENTRAL), the Database of Abstracts of Reviews of Effect (DARE) and PubMed in September 2018. The search terms ‘autoimmune inflammatory syndrome induced by adjuvants’, ‘breast implants’ and ‘silicone’ were used alone and in combination. **Results**: Thirty-four studies were reviewed, of which there were three case reports, 12 case series, 14 retrospective cohort studies, four case control studies and one prospective cohort study. Within this cohort, 18 studies were found regarding the explantation of implants relating to BII. **Conclusion**: Studies have demonstrated no association between silicone breast implants and any known autoimmune diseases, but there exists a pool of literature suggestive of a relatively undefined condition colloquially known as BII. Serological testing and imaging play an important role in the assessment of patients to exclude other pathology, but these tests remain non-diagnostic for BII. Although medical treatment has shown promise, there is no established treatment for patients. The surgical explantation of implants appears to have positive outcomes for patients; however, the exact nature of the surgery required to achieve this remains unclear.
first_indexed 2024-03-08T10:20:50Z
format Article
id doaj.art-9ff71baabad84cdda5ebf4fc9562a0a8
institution Directory Open Access Journal
issn 2209-170X
language English
last_indexed 2024-03-08T10:20:50Z
publishDate 2021-03-01
publisher Australian Society of Plastic Surgeons
record_format Article
series Australasian Journal of Plastic Surgery
spelling doaj.art-9ff71baabad84cdda5ebf4fc9562a0a82024-01-28T00:25:17ZengAustralian Society of Plastic SurgeonsAustralasian Journal of Plastic Surgery2209-170X2021-03-0141Diagnosis, investigation and management of breast implant illness: a narrative reviewDaniel WH WongTai K Lam**Introduction**: An increasing pool of literature proposes a link between silicone implants and autoimmune-related symptoms known colloquially as breast implant illness (BII). We describe the history of BII, the reported symptoms, risk factors and previously published diagnostic criteria with the aim to aid clinicians in the diagnosis, investigations and management of patients presenting with symptoms that they attribute to their silicone breast implants. **Methods**: A literature search was performed using MEDLINE®, the Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials (CENTRAL), the Database of Abstracts of Reviews of Effect (DARE) and PubMed in September 2018. The search terms ‘autoimmune inflammatory syndrome induced by adjuvants’, ‘breast implants’ and ‘silicone’ were used alone and in combination. **Results**: Thirty-four studies were reviewed, of which there were three case reports, 12 case series, 14 retrospective cohort studies, four case control studies and one prospective cohort study. Within this cohort, 18 studies were found regarding the explantation of implants relating to BII. **Conclusion**: Studies have demonstrated no association between silicone breast implants and any known autoimmune diseases, but there exists a pool of literature suggestive of a relatively undefined condition colloquially known as BII. Serological testing and imaging play an important role in the assessment of patients to exclude other pathology, but these tests remain non-diagnostic for BII. Although medical treatment has shown promise, there is no established treatment for patients. The surgical explantation of implants appears to have positive outcomes for patients; however, the exact nature of the surgery required to achieve this remains unclear.https://doi.org/10.34239/ajops.v4n1.210
spellingShingle Daniel WH Wong
Tai K Lam
Diagnosis, investigation and management of breast implant illness: a narrative review
Australasian Journal of Plastic Surgery
title Diagnosis, investigation and management of breast implant illness: a narrative review
title_full Diagnosis, investigation and management of breast implant illness: a narrative review
title_fullStr Diagnosis, investigation and management of breast implant illness: a narrative review
title_full_unstemmed Diagnosis, investigation and management of breast implant illness: a narrative review
title_short Diagnosis, investigation and management of breast implant illness: a narrative review
title_sort diagnosis investigation and management of breast implant illness a narrative review
url https://doi.org/10.34239/ajops.v4n1.210
work_keys_str_mv AT danielwhwong diagnosisinvestigationandmanagementofbreastimplantillnessanarrativereview
AT taiklam diagnosisinvestigationandmanagementofbreastimplantillnessanarrativereview